Physician profile
Gregory Stewart
NPI 1487888558
$5,594.73
in general payments reported to CMS, 2019-2025
37 companies · $1,224 in 2025
The $1,224 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $681 · 2020: $426 · 2021: $773 · 2022: $813 · 2023: $839 · 2024: $839 · 2025: $1,224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,874 · Education: $27.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,874.49 |
| Education | $27.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $913.19 | 2019-2025 | Lupron Depot, Botox |
| Astellas Pharma US INC | $695.83 | 2019-2023 | Myrbetriq, Veozah |
| Boston Scientific Corporation | $537.87 | 2019-2025 | Ams 700, Rezum Generator, Advantage System |
| Janssen Biotech, INC. | $464.01 | 2019-2025 | Erleada, Akeega, Balversa |
| Sumitomo Pharma America, INC. | $427.30 | 2023-2025 | Gemtesa, Orgovyx |
| Rochester Medical Corporation | $326.26 | 2019-2022 | |
| Urogen Pharma, INC. | $253.71 | 2021-2025 | Jelmyto |
| Endo Pharmaceuticals INC. | $217.86 | 2019-2022 | |
| Urovant Sciences INC | $214.27 | 2021-2022 | |
| Laborie Medical Technologies Corp. | $149.15 | 2020-2025 | Optilume Bph Drug Coated Balloon Catheter, Endosheath Technology |
| Procept Biorobotics Corporation | $148.78 | 2022-2025 | |
| Coloplast Corp | $128.54 | 2020-2024 | Speedicath |
| Medtronic, INC. | $85.48 | 2021-2025 | Interstim |
| Myovant Sciences INC. | $85.36 | 2021-2022 | |
| Tolmar, INC. | $77.74 | 2025 | Eligard, Jatenzo |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $76.23 | 2025 | 1788 |
| 180 Medical, INC. | $70.41 | 2020-2025 | |
| Allergan, INC. | $63.74 | 2022 | |
| Mission Pharmacal Company | $56.38 | 2019-2021 | |
| Valencia Technologies Corporation | $55.58 | 2025 | Ecoin Device Kit |
| Progenics Pharmaceuticals, INC. | $54.35 | 2023 | Pylarify |
| Edap Technomed INC | $54.00 | 2024 | |
| Ferring Pharmaceuticals INC. | $51.42 | 2019-2024 | Adstiladrin |
| Clarus Therapeutics INC. | $47.17 | 2021 | |
| Olympus America INC. | $44.95 | 2023 | Itind System |
| Accord Healthcare, INC. | $42.38 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.67 | 2021 | |
| Endo USA, INC. | $30.56 | 2025 | Xiaflex |
| Axonics, INC. | $26.40 | 2023-2024 | Bulkamid |
| Antares Pharma, INC. | $25.13 | 2022 | |
| Dendreon Pharmaceuticals LLC | $24.58 | 2019 | |
| Blue Earth Diagnostics | $21.35 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $20.92 | 2023 | Bard Urinary Drainage Bag |
| Travere Therapeutics, INC. | $20.52 | 2019 | |
| Abc Home Medical Supply, INC. | $19.29 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $15.38 | 2023 | Seglentis |
| Tolmar Pharmaceuticals, INC. | $14.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Stewart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.